药物组合-话题@MedSci

#药物组合#

22篇内容 | 1435人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2233722, encodeId=74492233e224a, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a>, objectTitle=中国多中心研究探索哪种化疗联合放疗治疗结外NK/T细胞淋巴瘤最优, objectType=article, longId=848774, objectId=5b44848e74f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720669414779_5579292.png, objectUrl=/article/show_article.do?id=5b44848e74f3, replyNumber=0, likeNumber=9, createdTime=2024-10-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b44848e74f3, moduleTitle=中国多中心研究探索哪种化疗联合放疗治疗结外NK/T细胞淋巴瘤最优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b44848e74f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2007223, encodeId=daae200e2232a, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Cell Death Dis：BH3-only蛋白表达水平决定肝细胞癌患者对基于索拉非尼的药物组合治疗的反应, objectType=article, longId=214946, objectId=404121494698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=404121494698, replyNumber=0, likeNumber=89, createdTime=2021-11-15, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=404121494698, moduleTitle=Cell Death Dis：BH3-only蛋白表达水平决定肝细胞癌患者对基于索拉非尼的药物组合治疗的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=404121494698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007222, encodeId=d23a200e22228, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Front Pharmacol：通过转录组学和网络特征预测前列腺癌的协同药物组合研究, objectType=article, longId=212065, objectId=c016212065e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c016212065e2, replyNumber=0, likeNumber=75, createdTime=2021-06-14, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c016212065e2, moduleTitle=Front Pharmacol：通过转录组学和网络特征预测前列腺癌的协同药物组合研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c016212065e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007221, encodeId=dd0d200e221ca, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Cancer cell：科学家开发出人工智能系统，让AI为癌症患者匹配更佳药物组合, objectType=article, longId=202625, objectId=6bfa2026251c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bfa2026251c, replyNumber=0, likeNumber=75, createdTime=2020-12-27, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bfa2026251c, moduleTitle=Cancer cell：科学家开发出人工智能系统，让AI为癌症患者匹配更佳药物组合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bfa2026251c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007220, encodeId=fff4200e220b7, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=CTLA4单抗ipilimumab和PD-1单抗nivolumab联合的临床研究证实：该药物组合对晚期肾细胞癌患有明显治疗优势, objectType=article, longId=166310, objectId=318316631011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=318316631011, replyNumber=0, likeNumber=72, createdTime=2020-01-12, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=318316631011, moduleTitle=CTLA4单抗ipilimumab和PD-1单抗nivolumab联合的临床研究证实：该药物组合对晚期肾细胞癌患有明显治疗优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=318316631011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007218, encodeId=5096200e218bb, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, objectType=article, longId=139275, objectId=a4201392e56f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4201392e56f, replyNumber=0, likeNumber=76, createdTime=2018-12-09, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4201392e56f, moduleTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4201392e56f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007219, encodeId=5e62200e21917, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线, objectType=article, longId=163430, objectId=0db916343049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0db916343049, replyNumber=0, likeNumber=90, createdTime=2019-06-09, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0db916343049, moduleTitle=诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0db916343049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007217, encodeId=74ef200e217e2, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=浅谈药物组合物专利特点及独权的写法, objectType=article, longId=118974, objectId=1d6e1189e4cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d6e1189e4cb, replyNumber=0, likeNumber=91, createdTime=2018-06-05, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d6e1189e4cb, moduleTitle=浅谈药物组合物专利特点及独权的写法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d6e1189e4cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007215, encodeId=1100200e215f0, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=重磅！ViiV&nbspHealthcare&nbspHIV新型药物组合3期临床试验获得成功, objectType=article, longId=90598, objectId=dd06905989e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd06905989e, replyNumber=0, likeNumber=56, createdTime=2017-05-19, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd06905989e, moduleTitle=重磅！ViiV&nbspHealthcare&nbspHIV新型药物组合3期临床试验获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd06905989e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007216, encodeId=920c200e2165b, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Hypertension：低剂量降血压药物组合效果理想，副作用更少, objectType=article, longId=100875, objectId=acb21008e569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acb21008e569, replyNumber=0, likeNumber=79, createdTime=2018-04-08, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acb21008e569, moduleTitle=Hypertension：低剂量降血压药物组合效果理想，副作用更少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acb21008e569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007211, encodeId=df4c200e21164, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=STM：birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望, objectType=article, longId=68846, objectId=e02468846d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02468846d4, replyNumber=0, likeNumber=66, createdTime=2016-09-23, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02468846d4, moduleTitle=STM：birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e02468846d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007212, encodeId=3617200e212ea, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=警惕！这9种致命的药物组合及预防方法, objectType=article, longId=72351, objectId=be8be235196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be8be235196, replyNumber=0, likeNumber=84, createdTime=2017-03-22, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be8be235196, moduleTitle=警惕！这9种致命的药物组合及预防方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be8be235196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007214, encodeId=0ff2200e2145a, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=精准癌症治疗：上百个致癌突变-药物组合被揭示, objectType=article, longId=75300, objectId=75bce53006d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75bce53006d, replyNumber=0, likeNumber=60, createdTime=2016-08-29, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75bce53006d, moduleTitle=精准癌症治疗：上百个致癌突变-药物组合被揭示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75bce53006d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007213, encodeId=66bf200e21371, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Oncotarget：新型免疫疗法药物组合或可有效治疗癌症, objectType=article, longId=72830, objectId=df74e28302a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df74e28302a, replyNumber=0, likeNumber=66, createdTime=2017-03-23, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df74e28302a, moduleTitle=Oncotarget：新型免疫疗法药物组合或可有效治疗癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df74e28302a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007210, encodeId=5f35200e210b7, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Science子刊：新型药物组合可有效治疗耐药性白血病, objectType=article, longId=68769, objectId=508d68e698c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508d68e698c, replyNumber=0, likeNumber=81, createdTime=2016-05-21, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508d68e698c, moduleTitle=Science子刊：新型药物组合可有效治疗耐药性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508d68e698c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007209, encodeId=138a200e2093e, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=NEJM：新型药物组合或为肺部囊性纤维化患者带来福音, objectType=article, longId=50975, objectId=c217509e50a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c217509e50a, replyNumber=0, likeNumber=76, createdTime=2016-03-15, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c217509e50a, moduleTitle=NEJM：新型药物组合或为肺部囊性纤维化患者带来福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c217509e50a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007208, encodeId=7557200e2084f, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=JACC：心房纤颤高危患者更安全的药物组合, objectType=article, longId=47922, objectId=79a34e922e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a34e922e6, replyNumber=0, likeNumber=73, createdTime=2015-08-23, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a34e922e6, moduleTitle=JACC：心房纤颤高危患者更安全的药物组合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79a34e922e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007207, encodeId=8922200e20793, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=Science：药物组合帮巨噬细胞“吃掉”肿瘤, objectType=article, longId=20348, objectId=9da3203482c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da3203482c, replyNumber=0, likeNumber=76, createdTime=2013-08-04, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da3203482c, moduleTitle=Science：药物组合帮巨噬细胞“吃掉”肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da3203482c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007204, encodeId=fa95200e2046b, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=阿斯利康anastrozole + fulvestrant药物组合显著改善激素相关性乳腺癌患者生存, objectType=article, longId=8529, objectId=971a852982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=971a852982, replyNumber=0, likeNumber=75, createdTime=2013-02-18, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=971a852982, moduleTitle=阿斯利康anastrozole + fulvestrant药物组合显著改善激素相关性乳腺癌患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=971a852982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2007206, encodeId=530d200e20645, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a>, objectTitle=J HEPATOL：博赛泼维药物组合治晚期纤维化/肝硬化安全有效, objectType=article, longId=12833, objectId=461212833c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=461212833c3, replyNumber=0, likeNumber=87, createdTime=2013-11-26, rootId=0, userName=12498dd9m11暂无昵称, userId=b3ad2500191, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=461212833c3, moduleTitle=J HEPATOL：博赛泼维药物组合治晚期纤维化/肝硬化安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=461212833c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药物组合

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#药物组合# #结外NK/T细胞淋巴瘤#

中国多中心研究探索哪种化疗联合放疗治疗结外NK/T细胞淋巴瘤最优

2024-10-28发表于上海

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Cell Death Dis：BH3-only蛋白表达水平决定肝细胞癌患者对基于索拉非尼的药物组合治疗的反应

2021-11-15

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Front Pharmacol：通过转录组学和网络特征预测前列腺癌的协同药物组合研究

2021-06-14

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Cancer cell：科学家开发出人工智能系统，让AI为癌症患者匹配更佳药物组合

2020-12-27

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

CTLA4单抗ipilimumab和PD-1单抗nivolumab联合的临床研究证实：该药物组合对晚期肾细胞癌患有明显治疗优势

2020-01-12

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤

2018-12-09

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线

2019-06-09

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

浅谈药物组合物专利特点及独权的写法

2018-06-05

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

重磅！ViiV&nbspHealthcare&nbspHIV新型药物组合3期临床试验获得成功

2017-05-19

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Hypertension：低剂量降血压药物组合效果理想，副作用更少

2018-04-08

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

STM：birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望

2016-09-23

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

警惕！这9种致命的药物组合及预防方法

2017-03-22

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

精准癌症治疗：上百个致癌突变-药物组合被揭示

2016-08-29

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Oncotarget：新型免疫疗法药物组合或可有效治疗癌症

2017-03-23

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Science子刊：新型药物组合可有效治疗耐药性白血病

2016-05-21

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

NEJM：新型药物组合或为肺部囊性纤维化患者带来福音

2016-03-15

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

JACC：心房纤颤高危患者更安全的药物组合

2015-08-23

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

Science：药物组合帮巨噬细胞“吃掉”肿瘤

2013-08-04

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

阿斯利康anastrozole + fulvestrant药物组合显著改善激素相关性乳腺癌患者生存

2013-02-18

12498dd9m11暂无昵称 (审核中...)

前往app查看评论内容

#药物组合#

J HEPATOL：博赛泼维药物组合治晚期纤维化/肝硬化安全有效

2013-11-26

科室
- - 订阅+
  - 更多科室
工具
服务